BioXcel Therapeutics Correlations
BTAI Stock | USD 2.33 0.03 1.27% |
The current 90-days correlation between BioXcel Therapeutics and Elevation Oncology is 0.11 (i.e., Average diversification). The correlation of BioXcel Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
BioXcel Therapeutics Correlation With Market
Average diversification
The correlation between BioXcel Therapeutics and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioXcel Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
BioXcel |
Moving together with BioXcel Stock
0.66 | CDIOW | Cardio Diagnostics | PairCorr |
0.71 | ELVN | Enliven Therapeutics | PairCorr |
0.92 | SCLX | Scilex Holding | PairCorr |
0.87 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.64 | CDIO | Cardio Diagnostics | PairCorr |
0.65 | CMND | Clearmind Medicine Common | PairCorr |
0.75 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.67 | CAT | Caterpillar | PairCorr |
0.77 | MSFT | Microsoft | PairCorr |
0.76 | MRK | Merck Company | PairCorr |
Moving against BioXcel Stock
0.91 | LUCD | Lucid Diagnostics | PairCorr |
0.9 | WM | Waste Management | PairCorr |
0.76 | GE | GE Aerospace | PairCorr |
0.57 | PG | Procter Gamble | PairCorr |
0.54 | PLX | Protalix Biotherapeutics | PairCorr |
0.89 | T | ATT Inc Earnings Call Today | PairCorr |
0.87 | JNJ | Johnson Johnson | PairCorr |
0.82 | IBM | International Business | PairCorr |
0.74 | CSCO | Cisco Systems | PairCorr |
0.7 | MMM | 3M Company | PairCorr |
0.66 | INTC | Intel | PairCorr |
0.6 | CVX | Chevron Corp Sell-off Trend | PairCorr |
0.55 | DD | Dupont De Nemours | PairCorr |
0.55 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BioXcel Stock performing well and BioXcel Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioXcel Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TERN | 3.05 | (0.92) | 0.00 | (1.16) | 0.00 | 5.03 | 19.13 | |||
AMLX | 3.64 | 0.00 | 0.00 | (0.06) | 0.00 | 7.20 | 21.45 | |||
ABOS | 2.99 | (0.64) | 0.00 | (0.59) | 0.00 | 6.57 | 19.77 | |||
INZY | 4.07 | (1.42) | 0.00 | (0.89) | 0.00 | 6.82 | 36.29 | |||
XFOR | 6.27 | (0.67) | 0.00 | (1.77) | 0.00 | 10.87 | 68.45 | |||
DAWN | 2.87 | (0.52) | 0.00 | (0.64) | 0.00 | 6.36 | 22.86 | |||
MRTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
APLS | 2.14 | (0.37) | 0.00 | (0.43) | 0.00 | 4.11 | 20.77 | |||
EXEL | 1.64 | 0.13 | 0.06 | 0.25 | 2.55 | 4.41 | 14.29 | |||
TGTX | 2.93 | 0.55 | 0.19 | 0.93 | 2.74 | 7.64 | 18.67 |
BioXcel Therapeutics Corporate Management
Javier JD | Chief VP | Profile | |
Frank Yocca | Chief Scientific Officer | Profile | |
Mary Coleman | VP Relations | Profile | |
Javier Rodriguez | Chief VP | Profile | |
Cedric Burg | VP Management | Profile | |
Robert Scala | Vice Planning | Profile |